Join Riverfront Times Press Club. Because No News is Bad News.

Friday, March 9, 2012

Researchers Discover Marker That Predicts Speed of Mental Decline from Alzheimer's

Posted By on Fri, Mar 9, 2012 at 7:30 AM

This is how a brain cell dies.
  • This is how a brain cell dies.

If you're at all prone to hypochondria, here's another thing to keep you up late worrying:

Researchers at Washington University Medical School have discovered a new marker that shows how rapidly your mental faculties will decline, should you develop Alzheimer's. In a recent study, patients with a higher level of the marker, visinin-like protein 1 (or VILIP-1 for short) had greater damage to their brain cells within a shorter amount of time and started to lose their memories and ability to think much more quickly.

The study was a small one -- only 60 patients in the early stages of Alzheimer's -- but the researchers were confident enough to publish their findings in the most recent issue of Neurology.

"VILIP-1 appears to be a strong indicator of ongoing injury to brain cells as a result of Alzheimer's disease," lead author Dr. Rawan Tarawneh, MD, now an assistant professor of neurology at the University of Jordan, said in a statement. "That could be very useful in predicting the course of the disease and in evaluating new treatments in clinical trials."

Over the course of the study, the researchers recruited 60 patients with mild Alzheimer's, took samples of their spinal fluid to check for VILIP-1 and then administered a series of cognitive tests. It appeared that the higher levels of VILIP-1 corresponded to lower levels of mental ability.

Previously, doctors tracked the progress of Alzheimer's by looking at levels of two other proteins in spinal fluid, amyloid beta and tau. But, says Tarawneh, the presence of amyloid beta and tau in the spine only meant that the proteins were also starting to form deposits in the brain. VILIP-1 appears to show how much brain cells have actually been damaged by the disease.

The next step will be for the researchers to set up a much larger study to see if the hypothesis holds true among a larger population. Tarawneh has confidence, though, in VILIP-1.

"In patients with early symptoms of Alzheimer's disease," she said, "VILIP-1 seems to be at least as good as -- and potentially even better than -- the other prognostic indicators we used in the study."

Tags: , ,

Riverfront Times works for you, and your support is essential.

Our small but mighty local team works tirelessly to bring you high-quality, uncensored news and cultural coverage of St. Louis and beyond.

Unlike many newspapers, ours is free – and we'd like to keep it that way, because we believe, now more than ever, everyone deserves access to accurate, independent coverage of their community.

Whether it's a one-time acknowledgement of this article or an ongoing pledge, your support helps keep St. Louis' true free press free.

Read the Digital Print Issue

October 14, 2020

View more issues


Never miss a beat

Sign Up Now

Subscribe now to get the latest news delivered right to your inbox.

Best Things to Do In St. Louis

© 2020 Riverfront Times

Website powered by Foundation